-
Business
CareerBuilder + Monster Files for Bankruptcy in Breakup Sale to JobGet, Valnet, Valsoft
CareerBuilder + Monster, the once-dominant forces in online job search, have filed for Chapter 11 bankruptcy less than a year…
Read More » -
Business
Fed Signals No Rush on Rate Cuts as Tariff Uncertainty Clouds Outlook
Federal Reserve Chair Jerome Powell told Congress the Fed will hold rates steady amid inflation uncertainty driven by new tariffs.…
Read More » -
Business
Carnival Raises Outlook as Cruise Demand Holds, Bets Big on Private-Island Strategy
Carnival Corp. lifted its full-year profit forecast after posting stronger-than-expected Q2 revenue, fueled by solid cruise demand and rising onboard…
Read More » -
Business
T-Mobile to Launch Satellite App Access Nationwide by October
T-Mobile will begin offering satellite-powered messaging in July and full data service by October, marking a first for U.S. carriers.…
Read More » -
Business
Insurers Agree to Slash Prior Authorization Red Tape Under Pressure from Kennedy, CMS
Six major health insurers have pledged to overhaul the prior authorization system that clogs U.S. healthcare, marking a rare moment…
Read More » -
Business
Wall Street Rally: Fed Signals, Tesla Spike, and SPY Hits Record High
Wall Street rally gains traction with dovish Fed tone, an 8% Tesla surge, and geopolitical relief. SPY sets a new…
Read More » -
Business
Northern Trust Pushes Back on Merger Chatter, Affirms Independence Amid BNY Mellon Overtures
Northern Trust publicly rejected merger speculation with BNY Mellon, reaffirming its independence after reports of a recent overture. While investors…
Read More » -
Business
Novo Nordisk Cuts Off Hims & Hers Over Wegovy Dispute, Putting a Spotlight on Telehealth’s Regulatory Edge
Novo Nordisk abruptly ended its partnership with Hims & Hers, citing the illegal distribution of compounded Wegovy alternatives. The fallout…
Read More » -
Business
BNY Mellon in Quiet Merger Talks with Northern Trust That Could Redefine Custody Banking
BNY Mellon has started early merger talks with Northern Trust in a possible $3 trillion custody shake-up. No deal is…
Read More » -
Business
Lilly Eyes 2025 Approval for Obesity Pill as Pivotal Phase 3 Trial Approaches
Eli Lilly’s orforglipron, a once-daily oral weight-loss pill, is set to enter a pivotal Phase 3 trial in non-diabetic obese…
Read More »
